- Home
- ZVIA vs VOR Comparison
ZVIA vs VOR Comparison
Compare ZVIA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- VOR
- Stock Information
- Founded
- ZVIA 2007
- VOR 2015
- Country
- ZVIA United States
- VOR United States
- Employees
- ZVIA N/A
- VOR N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- ZVIA Consumer Staples
- VOR Health Care
- Exchange
- ZVIA Nasdaq
- VOR Nasdaq
- Market Cap
- ZVIA 193.4M
- VOR 207.1M
- IPO Year
- ZVIA 2021
- VOR 2021
- Fundamental
- Price
- ZVIA $2.69
- VOR $7.98
- Analyst Decision
- ZVIA Buy
- VOR Buy
- Analyst Count
- ZVIA 5
- VOR 7
- Target Price
- ZVIA $4.89
- VOR $70.43
- AVG Volume (30 Days)
- ZVIA 787.3K
- VOR 1.0M
- Earning Date
- ZVIA 11-05-2025
- VOR 11-13-2025
- Dividend Yield
- ZVIA N/A
- VOR N/A
- EPS Growth
- ZVIA N/A
- VOR N/A
- EPS
- ZVIA N/A
- VOR N/A
- Revenue
- ZVIA $162,849,000.00
- VOR N/A
- Revenue This Year
- ZVIA $6.44
- VOR N/A
- Revenue Next Year
- ZVIA $6.68
- VOR N/A
- P/E Ratio
- ZVIA N/A
- VOR N/A
- Revenue Growth
- ZVIA 6.17
- VOR N/A
- 52 Week Low
- ZVIA $1.88
- VOR $2.62
- 52 Week High
- ZVIA $4.99
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- ZVIA 59.59
- VOR 24.79
- Support Level
- ZVIA $2.62
- VOR $6.50
- Resistance Level
- ZVIA $2.78
- VOR $8.77
- Average True Range (ATR)
- ZVIA 0.13
- VOR 1.06
- MACD
- ZVIA 0.01
- VOR -0.21
- Stochastic Oscillator
- ZVIA 69.12
- VOR 10.63
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.